Chat Live with a Dana-Farber Lymphoma Expert

0

Lymphoma: How do we treat it? Where are future therapies headed?

Ann LaCasce, MD

On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page.

LaCasce will discuss current treatment options as well as future therapies for lymphoma.

If you have a question for Dr. LaCasce, email webchats@dfci.harvard.edu. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat.

Bookmark the webchat video page and tune in live on Dec. 18 at 1 p.m. EST. You can also add the event to your calendar or RSVP on Facebook.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
Is No Treatment the Best Treatment for DCIS #BreastCancer? https://t.co/8sRwXAycQR #bcsm https://t.co/AiRV3HQRkl
Dana-Farber @danafarber
What Is the Difference Between Hodgkin #Lymphoma and Non-Hodgkin Lymphoma? [Infographic] https://t.co/8D8CEtpxDf https://t.co/91KxtKCvqD
Dana-Farber @danafarber
RT @exercise_cancer: Did u know u can access @DanaFarber Zakim Center's movement class schedule from home? Just click on calendar tab. htt…

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.